Research and Markets (http://www.researchandmarkets.com/research/mrmbhq/rhabdomyosarcomap) has announced the addition of the "Rhabdomyosarcoma-Pipeline Insights, 2015" subscription to their offering.
This Rhabdomyosarcoma Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Rhabdomyosarcoma.
This report provides information on the therapeutic development based on the Rhabdomyosarcoma dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Rhabdomyosarcoma Overview
- Rhabdomyosarcoma Pipeline Therapeutics
- Rhabdomyosarcoma Therapeutics under Development by Companies
- Rhabdomyosarcoma Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Rhabdomyosarcoma Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Rhabdomyosarcoma Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Rhabdomyosarcoma Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Rhabdomyosarcoma - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Rhabdomyosarcoma - Discontinued Products
- Rhabdomyosarcoma - Dormant Products
- Companies Involved in Therapeutics Development for Rhabdomyosarcoma
- Appendix
For more information visit http://www.researchandmarkets.com/research/mrmbhq/rhabdomyosarcomap
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals